Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Cirstea is a Medical Oncology Hospitalist in the Stem Cell Transplant program at Dana-Farber Cancer Institute and Brigham and Women's Hospital. She grew up and received her medical degree in the Republic of Moldova. Her passion for Hematology-Oncology ignited when she joined the Jerome Lipper Multiple Myeloma Center in 2006. Dr. Cirstea's research focused on novel anti-myeloma therapeutics including CDK inhibitors and agents targeting the PI3K/Akt/mTOR pathway both alone and in combination with conventional therapies. During her three-year hematology/oncology fellowship at Boston Medical Center she had the privilege to care for patients originating from diverse socio-economic and ethnic backgrounds, presenting with advanced malignancies, rare and often severe hematological conditions. She has also experienced the excitement of teaching medical students and residents in the hospital setting. As an attending physician on a Bone Marrow Transplant (BMT) ward her current clinical and research interests revolve around improving the hospital care of patients receiving stem cell transplants along with the teaching and supervision of medical residents during their BMT rotation.
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions